Approved for WEGOVY (semaglutide) injection is a GLP-1 receptor agonist indicated in combination with a reduced calorie diet and increased physical activity: to reduce the risk of major adverse cardiovascular events in adults with established cardiovascular disease and either obesity or overweight; to reduce excess body weight and maintain weight reduction long term in adults and pediatric…
Loading full data from Know Your Drugs Institute…